J. Raynov

发表

Diagnostic Significance of Biomarkers of Iron Deficiency for Anemia in Clinical Practice

N. Petkova, J. Raynov, D. Petrova, 2019, Folia medica.

Serum level changes of matrix metalloproteinases 2 and 9, vascular endothelial growth factor and epidermal growth factor receptor during platinum-based chemotherapy in advanced non-small cell lung cancer patients.

M. Tonato, G. Ceresoli, I. Floriani, 2007, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Rituximab maintenance overcomes the negative prognostic factor of obesity in CLL: Subgroup analysis of the international randomized AGMT CLL‐8a mabtenance trial

L. Pleyer, R. Greil, U. Jäger, 2019, Cancer medicine.

Thermo-induced modifications and selective accumulation of glucose-conjugated magnetic nanoparticles in vivo in rats – increasing the effectiveness of magnetic-assisted therapy – pilot study

J. Raynov, L. Traikov, R. Hadjiolova, 2015, Electromagnetic biology and medicine.

Rituximab maintenance versus observation alone in patients with chronic lymphocytic leukaemia who respond to first-line or second-line rituximab-containing chemoimmunotherapy: final results of the AGMT CLL-8a Mabtenance randomised trial.

L. Pleyer, R. Greil, U. Jäger, 2016, The Lancet. Haematology.

A Rare Case of Primary Histiocytic Sarcoma of the Stomach

M. Guenova, N. Petkova, J. Raynov, 2018, Folia medica.

Novel aspects of silver nanoparticles application in low intensity electromagnetic field

R. Bryaskova, D. Pencheva, T. Kantardjiev, 2018, 2018 EMF-Med 1st World Conference on Biomedical Applications of Electromagnetic Fields (EMF-Med).

A randomized, placebo-controlled, double blind, multicenter phase II adjuvant trial of the efficacy, immunogenicity, and safety of GI-4000 plus gem versus gem alone in patients with resected pancreas cancer with activating RAS mutations/survival and immunology analysis of the R1 subgroup.

F. Harrell, W. Fisher, A. Rosemurgy, 2012 .

Rituximab Maintenance after Chemoimmunotherapy Induction in 1st and 2nd Line Improves Progression Free Survival: Planned Interim Analysis of the International Randomized AGMT-CLL8/a Mabtenance Trial

R. Greil, U. Jäger, M. Steurer, 2014 .

Isolated 1q21 rearrangement der(20)t(1;20)(q21;p13) with telomere involvement of 20p in a case of longstanding myelodysplastic syndrome

J. Raynov, L. Mitev, Aselina Asenova, 2019, Atlas of Genetics and Cytogenetics in Oncology and Haematology.

Can genome array screening replace FISH as a front‐line test in multiple myeloma?

E. Nacheva, J. Raynov, C. Grace, 2014, Genes, chromosomes & cancer.

Health Care Resource Utilization (HCRU) In Hospitalized Febrile Neutropenia (FN) Patients Treated With Chemotherapy For Solid Tumors (ST) And Hematological Malignancies (HM) In Bulgaria.

G. Mihaylov, J. Raynov, Z. Mihaylova, 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

The prognostic significance of interphase cytogenetic abnormalities in chronic lymphocytic leukemia

E. Naseva, N. Petkova, J. Raynov, 2018 .

Neoadjuvant chemotherapy and targeted therapy in patients with liver metastases from colorectal cancer; medical oncologist's point of view.

J. Raynov, Z. Mihaylova, 2008, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Married couple both with myeloproliferative disorder and chromosome 3 abnormality

J. Raynov, D. Danchev, Y. Manolova, 1998, American journal of hematology.